Mayumi Ono

14.8k total citations · 1 hit paper
214 papers, 12.1k citations indexed

About

Mayumi Ono is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mayumi Ono has authored 214 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Molecular Biology, 67 papers in Oncology and 41 papers in Cancer Research. Recurrent topics in Mayumi Ono's work include Angiogenesis and VEGF in Cancer (51 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer, Hypoxia, and Metabolism (17 papers). Mayumi Ono is often cited by papers focused on Angiogenesis and VEGF in Cancer (51 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer, Hypoxia, and Metabolism (17 papers). Mayumi Ono collaborates with scholars based in Japan, United States and Spain. Mayumi Ono's co-authors include Michihiko Kuwano, Kimitoshi Kohno, Hiroto Izumi, Shigeo Yoshida, Kosuke Watari, M Kuwano, Tadahisa Shono, Akihiko Kawahara, Tatsuro Ishibashi and Yuji Basaki and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Mayumi Ono

212 papers receiving 11.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Involvement of Interleukin-8, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Tumor Necrosis Factor Alpha-Dependent Angiogenesis

1997 573 citations Mayumi Ono, Hiroto Izumi et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mayumi Ono	7.4k	4.0k	2.2k	1.9k	1.7k	214	12.1k
Gary E. Gallick	7.7k 1.0×	6.0k 1.5×	2.9k 1.3×	2.0k 1.0×	1.0k 0.6×	202	13.7k
Daniel E. Johnson	8.4k 1.1×	4.3k 1.1×	2.3k 1.0×	1.5k 0.8×	2.2k 1.2×	133	13.6k
Michihiko Kuwano	11.4k 1.5×	6.9k 1.7×	2.5k 1.2×	1.8k 1.0×	2.1k 1.2×	357	18.4k
Ugo Testa	8.7k 1.2×	3.0k 0.8×	2.7k 1.2×	1.3k 0.7×	3.7k 2.1×	423	16.9k
Holger Kalthoff	6.5k 0.9×	6.2k 1.6×	2.9k 1.3×	1.2k 0.6×	2.6k 1.5×	255	12.7k
David Stokoe	11.5k 1.6×	3.5k 0.9×	2.5k 1.1×	1.2k 0.6×	2.1k 1.2×	96	15.7k
Dean G. Tang	8.6k 1.2×	5.3k 1.3×	4.5k 2.1×	2.5k 1.3×	1.3k 0.7×	172	14.4k
Norman M. Greenberg	5.3k 0.7×	3.1k 0.8×	1.8k 0.8×	3.4k 1.8×	2.1k 1.2×	123	10.2k
Michael G. Brattain	6.8k 0.9×	4.1k 1.0×	1.7k 0.8×	912 0.5×	742 0.4×	219	10.3k
Hiroki Kuniyasu	5.4k 0.7×	3.1k 0.8×	2.2k 1.0×	1.6k 0.8×	1.0k 0.6×	277	10.3k

Countries citing papers authored by Mayumi Ono

Since Specialization

Citations

This map shows the geographic impact of Mayumi Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayumi Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayumi Ono more than expected).

Fields of papers citing papers by Mayumi Ono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayumi Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayumi Ono. The network helps show where Mayumi Ono may publish in the future.

Co-authorship network of co-authors of Mayumi Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Mayumi Ono. A scholar is included among the top collaborators of Mayumi Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayumi Ono. Mayumi Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sugita, Yasuo, Takuya Furuta, Kenji Takahashi, et al.. (2024). Elevated expression of N‐myc downstream regulated gene 1 protein in glioblastomas reflects tumor angiogenesis and poor patient prognosis. Neuropathology. 44(6). 422–431. 1 indexed citations

Tsuda, Naotake, Shin Nishio, Tomohiko Yamaguchi, et al.. (2022). N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-Catenin. The Kurume Medical Journal. 69(1.2). 39–46. 1 indexed citations

Imaizumi, Akira, Noritaka Komune, Mayumi Ono, et al.. (2021). Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinoma. FEBS Open Bio. 11(8). 2211–2224. 4 indexed citations

Shibata, Tomohiro, Kosuke Watari, Akihiko Kawahara, et al.. (2019). Targeting Phosphorylation of Y-Box–Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance. Molecular Cancer Therapeutics. 19(3). 882–894. 47 indexed citations

Ito, Hiroshi, Kosuke Watari, Tomohiro Shibata, et al.. (2019). Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma. Cancer Research. 80(2). 234–248. 26 indexed citations

Costa, Carlota, Miguel Angel Molina, Ana Drozdowskyj, et al.. (2014). The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR -Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial. Clinical Cancer Research. 20(7). 2001–2010. 180 indexed citations

Okazaki, Hiroyuki, Naoya Matsunaga, Takashi Fujioka, et al.. (2013). Circadian Regulation of mTOR by the Ubiquitin Pathway in Renal Cell Carcinoma. Cancer Research. 74(2). 543–551. 50 indexed citations

Kawahara, Akihiko, Kosuke Watari, Yûichi Murakami, et al.. (2013). Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling. Cancer Research. 73(20). 6243–6253. 129 indexed citations

Murakami, Yûichi, Kosuke Watari, Tomohiro Shibata, et al.. (2013). N-myc Downstream-regulated Gene 1 Promotes Tumor Inflammatory Angiogenesis through JNK Activation and Autocrine Loop of Interleukin-1α by Human Gastric Cancer Cells. Journal of Biological Chemistry. 288(35). 25025–25037. 39 indexed citations

10.

Okamoto, Kunio, Isamu Okamoto, Erina Hatashita, et al.. (2011). Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin. Molecular Cancer Therapeutics. 11(1). 204–213. 59 indexed citations

11.

Yamamoto, Chizuko, Yuji Basaki, Akihiko Kawahara, et al.. (2010). Loss of PTEN Expression by Blocking Nuclear Translocation of EGR1 in Gefitinib-Resistant Lung Cancer Cells Harboring Epidermal Growth Factor Receptor–Activating Mutations. Cancer Research. 70(21). 8715–8725. 141 indexed citations

12.

Hosoi, Fumihito, Hiroto Izumi, Akihiko Kawahara, et al.. (2009). N-myc Downstream Regulated Gene 1/Cap43 Suppresses Tumor Growth and Angiogenesis of Pancreatic Cancer through Attenuation of Inhibitor of κB Kinase β Expression. Cancer Research. 69(12). 4983–4991. 88 indexed citations

13.

Aoki, Daisuke, Yoshinao Oda, Satoshi Hattori, et al.. (2009). Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma. Clinical Cancer Research. 15(4). 1473–1480. 55 indexed citations

14.

Sohda, Makoto, Yasushi Mochida, Hiroyuki Kato, et al.. (2009). Overexpression of Cap43 is associated with malignant status of esophageal cancer.. PubMed. 29(4). 965–70. 11 indexed citations

15.

Zhao, Hong‐Ye, Akio Ooyama, Masatatsu Yamamoto, et al.. (2008). Molecular Basis for the Induction of an Angiogenesis Inhibitor, Thrombospondin-1, by 5-Fluorouracil. Cancer Research. 68(17). 7035–7041. 33 indexed citations

16.

Kimura, Yusuke, Kosuke Watari, Abbas Fotovati, et al.. (2007). Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Science. 98(12). 2009–2018. 108 indexed citations

17.

Oie, Shinji, Mayumi Ono, Hirohisa Yano, et al.. (2006). The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-α. International Journal of Oncology. 29(6). 1469–78. 14 indexed citations

18.

Nakao, Shintaro, Takashi Kuwano, Chikako Tsutsumi‐Miyahara, et al.. (2005). Infiltration of COX-2–expressing macrophages is a prerequisite for IL-1β–induced neovascularization and tumor growth. Journal of Clinical Investigation. 115(11). 2979–2991. 246 indexed citations

19.

Nishie, Akihiro, Katsuaki Masuda, Toshiro Migita, et al.. (2001). High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas.. PubMed. 7(7). 2145–51. 52 indexed citations

20.

Torisu, Hitoe, Mayumi Ono, Hiromaro Kiryu, et al.. (2000). Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL-1α. International Journal of Cancer. 85(2). 182–188. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact